Cite
HARVARD Citation
Hacking, N. et al. (2022). The impact on Anti-Mullerian Hormone (AMH), uterine fibroid size and uterine artery patency following Uterine Fibroid Embolization (UFE) with a resorbable embolic agent. Human fertility. pp. 881-887. [Online].